EUVIMEDEUVIMED entdecken
Crossref

Targeting S1PR1 with W146 Ameliorates autism-associated cognitive deficits by restoring neurovascular integrity via ERK/Caspase-3 pathway modulation

Gang Zhao, Xian Tian, Kangwei Peng, Lin Guo, Yuhuang Chen, Yonggang Cao, Hongmei Wu, Min Zhang

Pharmacology Biochemistry and Behavior · 2025

DOI: 10.1016/j.pbb.2025.174078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2025. Verfasst von Gang Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Health Care, Maternity and Child Healthcare Hospital of Nanshan District, 1 Wanxia Road, Nanshan District, Shenzhen 518067, China. Hauptthemen laut MEDLINE: Sphingosine-1-Phosphate Receptors, Autistic Disorder, Cognitive Dysfunction, Caspase 3. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Science, Technology and Innovation Commission of Shenzhen Municipality, Natural Science Foundation of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: We investigated the role of sphingosine-1-phosphate receptor 1 (S1PR1) in blood-brain barrier (BBB) function and associated behavioral abnormalities using the BTBR T + tf/J (BTBR) mouse model of autism. METHODS: Male C57BL/6 J (C57) and BTBR mice (4-week-old, n = 16/group) were assigned to three groups: C57 + Veh, BTBR+Veh, and BTBR+W146. The BTBR+W146 group received daily intraperitoneal injections of W146 (1 mg/kg) for 21 days, while control groups received equivalent volumes of vehicle (DMSO+0.9 % saline). Learning and memory were assessed using the Morris water maze. S1PR1 expression was determined via RT-PCR and Western blot analysis. Hippocampal neuronal morphology was examined by Nissl staining, while microvascular endothelial markers (CD31) and apoptotic pathway proteins (p-ERK, Caspase-3) were assessed by immunohistochemistry and Western blot. RESULTS: BTBR mice showed significantly higher hippocampal S1P and S1PR1 than C57 controls (P < 0.01). W146 treatment reduced escape latency and increased platform crossings in the Morris water maze (P < 0.05). Treatment with W146 also increased phospho-Ca2+/calmodulin-dependent protein kinase II (p-CaMKII), and phospho-cAMP-response element binding protein (p-CREB) expression in the hippocampus. Histologically, W146 restored neuronal density in the hippocampal CA1 region and preserved microvascular integrity, as shown by increased CD31 expression (P < 0.05). The observed neuroprotective effect was linked to significant decreases in the expression of phosphorylated ERK (P < 0.05) and Caspase-3 (P < 0.05). CONCLUSION: Elevated S1P/S1PR1 signaling in BTBR mice is associated with hippocampal neurovascular dysfunction. Treatment with the S1PR1 antagonist W146 improves learning and memory deficits, coinciding with reduced ERK/Caspase-3-mediated apoptotic signaling and preserved CA1 neuronal integrity. These findings highlight S1PR1 as a potential therapeutic target for autism-related cognitive impairments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sphingosine-1-Phosphate ReceptorsAutistic DisorderCognitive DysfunctionCaspase 3MAP Kinase Signaling SystemAnimalsMaleMiceMice, Inbred C57BLBlood-Brain BarrierHippocampusMaze LearningDisease Models, Animal

Stichwörter der Autor:innen

Autism spectrum disorderBTBR miceERK/Caspase-3Learning and memoryS1PR1

Substanzen

Sphingosine-1-Phosphate ReceptorsCaspase 3S1pr1 protein, mouseCasp3 protein, mouse

Autor:innen und Institutionen

  • Department of Child Health Care, Maternity and Child Healthcare Hospital of Nanshan District, 1 Wanxia Road, Nanshan District, Shenzhen 518067, China.
  • Department of Psychology, College of Nursing, Harbin Medical University in Daqing, Daqing, Heilongjiang 163319, China.
  • Department of Pharmacology, College of Basic Medical Sciences, Harbin Medical University in Daqing, Daqing, Heilongjiang 163319, China.
  • Department of Psychology, College of Nursing, Harbin Medical University in Daqing, Daqing, Heilongjiang 163319, China. Electronic address: wuhongmei@hmudq.edu.cn.
  • Department of Child Health Care, Maternity and Child Healthcare Hospital of Nanshan District, 1 Wanxia Road, Nanshan District, Shenzhen 518067, China. Electronic address: szdaisymin@126.com.

Förderung

  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Natural Science Foundation of Heilongjiang Province

Zitieren

APA

Zhao, G., Tian, X., Peng, K., Guo, L., Chen, Y., Cao, Y., Wu, H., & Zhang, M. (2025). Targeting S1PR1 with W146 Ameliorates autism-associated cognitive deficits by restoring neurovascular integrity via ERK/Caspase-3 pathway modulation. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2025.174078

Vancouver

Zhao G, Tian X, Peng K, Guo L, Chen Y, Cao Y, et al. Targeting S1PR1 with W146 Ameliorates autism-associated cognitive deficits by restoring neurovascular integrity via ERK/Caspase-3 pathway modulation. Pharmacology Biochemistry and Behavior. 2025. doi:10.1016/j.pbb.2025.174078

BibTeX
@article{Zhao2025,
  author = {Zhao, Gang and Tian, Xian and Peng, Kangwei and Guo, Lin and Chen, Yuhuang and Cao, Yonggang and Wu, Hongmei and Zhang, Min},
  title = {Targeting S1PR1 with W146 Ameliorates autism-associated cognitive deficits by restoring neurovascular integrity via ERK/Caspase-3 pathway modulation},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2025},
  doi = {10.1016/j.pbb.2025.174078}
}
Kostenlos starten →